Diagnostic News and Research

RSS

Majority of doctors resort to defensive medicine practices, says survey

A survey by Mount Sinai School of Medicine researchers has found that 91 percent of physicians believe concerns over malpractice lawsuits result in "defensive medicine," ordering more tests and procedures than necessary as a protective measure. The study, which questioned 2,416 physicians, is published in the June 28 edition of Archives of Internal Medicine.

29 Jun 2010

Simple blood test may help detect chromosomal abnormalities in developing foetus

Researchers in The Netherlands believe they are on the verge of developing a simple, prenatal blood test that would be able to detect accurately chromosomal abnormalities in the developing foetus.

29 Jun 2010

New ISR's report highlights current and future adoption of biomarker technologies

Industry Standard Research (ISR) today announced the release of The State of Biomarkers in Drug Development report. 44 pharmaceutical and biotechnology professionals provided their strategies, insights, and predictions in this snapshot of a rapidly evolving market. In total, 37 significant pharma and biotech companies contributed to this endeavor.

29 Jun 2010

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the agreement, Signature Dx obtains a worldwide license to use Affymetrix® microarray technology to develop and commercialize diagnostic and prognostic colorectal cancer (CRC) tests.

29 Jun 2010

High-risk insurance program in Pennsylvania for uninsured individuals with pre-existing medical conditions

The federal government has approved Pennsylvania's application to offer a high-risk insurance program for uninsured individuals who have pre-existing medical conditions, state Insurance Commissioner Joel Ario said today.

29 Jun 2010

Image-guided percutaneous biopsies on the rise

Advanced imaging technologies have helped shift biopsy techniques away from more invasive approaches toward imaging-guided percutaneous-or through the skin-techniques, according to a new study appearing online and in the September print edition of the journal Radiology.

29 Jun 2010

Non-Invasive prenatal blood test to detect chromosomal abnormalities in foetus

Researchers in The Netherlands believe they are on the verge of developing a simple, prenatal blood test that would be able to detect accurately chromosomal abnormalities in the developing foetus. At present, the only reliable way to do this is through amniocentesis or chorionic villus sampling, both of which are invasive and carry the risk of triggering a miscarriage.

29 Jun 2010

Meniscal, cruciate ligament lesions increase risk of knee osteoarthritis

Arthroscopic surgical repair of torn anterior cruciate ligaments (ACL) or meniscal cartilage injuries in the knee does not decrease the chances of developing osteoarthritis, according to a new study published in the online edition and August print issue of the journal Radiology.

29 Jun 2010

Failed ACL surgeries are more common than previously thought

Nick Van Erp, active in soccer since elementary school and lacrosse since junior high, tore the anterior cruciate ligament in his knee during a spring lacrosse game his freshman year of high school. His injury, caused by stepping into a pothole and hyper-extending his knee, required surgical repair, ending his season prematurely and the remainder of his high school sports career.

29 Jun 2010

Endometriosis can affect women's work productivity

The first worldwide study of the societal impact of endometriosis has found a significant loss of work productivity among those women who suffer from the condition, a researcher told the 26th annual meeting of the European Society of Human Reproduction and Embryology today (Monday).

29 Jun 2010

New diagnostic tool may help detect HPV and other viruses

A cluster of carbon nanotubes coated with a thin layer of protein-recognizing polymer form a biosensor capable of using electrochemical signals to detect minute amounts of proteins, which could provide a crucial new diagnostic tool for the detection of a range of illnesses, a team of Boston College researchers report in the journal Nature Nanotechnology.

29 Jun 2010

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that it has entered into a technology integration and development agreement with Lydall, Inc..

29 Jun 2010

Cell>Point completes cancer diagnostic phase 2 trial; reports favorable trends in primary tumor imaging

Cell>Point announced today that it has closed the Phase 2 portion of its Phase 2/3 trial of 99mTc-EC-G in evaluating patients with non-small cell lung cancer.

29 Jun 2010

Harris leverages CONNECT solution to enhance capabilities of Bidirectional Health Information Exchange interface

Harris Corporation, as a subcontractor to Evolvent Technologies, Inc., is helping to improve the quality of military patient care provided by enhancing the capabilities of the Bidirectional Health Information Exchange (BHIE) interface. The exchange is a health enterprise integration capability employed by the Department of Defense (DoD) and the Department of Veterans Affairs (VA) to securely share patient information between agencies.

28 Jun 2010

Bayonne Medical Center implements Picis ED PulseCheck ahead of schedule

Picis announced today that Bayonne Medical Center, Bayonne, NJ, has successfully deployed Picis ED PulseCheck™, part of the CareSuite® family of high-acuity solutions, two months ahead of schedule. This aggressive implementation is aimed at helping clinicians in the emergency department (ED) better manage information and the process of treating over 28,000 ED patients annually.

28 Jun 2010

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

Yesterday, the Association for Molecular Pathology (AMP) gave public comments at the FDA's Center for Devices and Radiological Health (CDRH) Council meeting on Medical Device Innovation: Barriers to Market for Molecular Diagnostic Tests.

28 Jun 2010

Today's OpEds: A new breed of medical education, more on the Medicare 'doc fix,' efforts to cut health care waste

Medical schools in particular may transform the way healthcare is practiced and viewed by the general community and its leaders. The medical school with this focus will not only pursue traditional missions like research and teaching students diagnostic skills but also emphasize community involvement, local medicine, social consciousness and local cultural issues (Dr. John Rock, 6/28).

28 Jun 2010

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.

28 Jun 2010

Zeria reports positive results from Japanese Phase III study of Z-338 for functional dyspepsia

Zeria Pharmaceutical announced today positive results of their Japanese Phase III study of Z-338 (acotiamide hydrochloride hydrate; "acotiamide") for the treatment of functional dyspepsia (FD). FD is a gastrointestinal disease comprised of subjective symptoms including postprandial fullness, early satiation and epigastric pain without any organic abnormality on gastrointestinal tract.

28 Jun 2010

Aeterna Zentaris, Almac collaborate on study of AEZS-108 doxorubicin LHRH targeted conjugate compound

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.

28 Jun 2010

Diagnostic News and Research

Majority of doctors resort to defensive medicine practices, says survey

Simple blood test may help detect chromosomal abnormalities in developing foetus

New ISR's report highlights current and future adoption of biomarker technologies

Signature Dx obtains worldwide license to Affymetrix microarray technology for development of CRC tests

High-risk insurance program in Pennsylvania for uninsured individuals with pre-existing medical conditions

Image-guided percutaneous biopsies on the rise

Non-Invasive prenatal blood test to detect chromosomal abnormalities in foetus

Meniscal, cruciate ligament lesions increase risk of knee osteoarthritis

Failed ACL surgeries are more common than previously thought

Endometriosis can affect women's work productivity

New diagnostic tool may help detect HPV and other viruses

Shrink Nanotechnologies, Lydall enter technology integration and development agreement

Cell>Point completes cancer diagnostic phase 2 trial; reports favorable trends in primary tumor imaging

Harris leverages CONNECT solution to enhance capabilities of Bidirectional Health Information Exchange interface

Bayonne Medical Center implements Picis ED PulseCheck ahead of schedule

AMP comments on barriers to market for molecular diagnostic tests at FDA CDRH meeting

Today's OpEds: A new breed of medical education, more on the Medicare 'doc fix,' efforts to cut health care waste

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Zeria reports positive results from Japanese Phase III study of Z-338 for functional dyspepsia

Aeterna Zentaris, Almac collaborate on study of AEZS-108 doxorubicin LHRH targeted conjugate compound

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News